RecruitingNCT06270056

Evaluation of Telemedicine Medical Abortion Service in Ecuador

Evaluation of Telemedicine Services to Address Urgent Issues Related to Sexual and Reproductive Rights in Ecuador


Sponsor

Gynuity Health Projects

Enrollment

100 participants

Start Date

Jul 24, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.


Eligibility

Sex: FEMALEMin Age: 15 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Misoprostol for people with pregnancy. The study is currently recruiting participants at 3 locations. People eligible for this study include women aged 15 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMisoprostol

Self-administered misoprostol by clients obtaining medication abortion via telemedicine


Locations(3)

El Comité de Derechos Sexuales y Reproductivos de Ecuador (CODESER)

Ambato, Ecuador

Cemoplaf

Quito, Ecuador

Federación Nacional de Obstetrices y Obstetras del Ecuador (FENOE)

Quito, Ecuador

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06270056


Related Trials